Cardionomic's Series B Round

Cardionomic raised a round of funding on April 30, 2018. Investors include Ascension Ventures.

Cardionomic addresses Acute Decompensated Heart Failure's root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output theref…

Articles about Cardionomic's Series B Round: